Publications by authors named "Donna Messner"

Claim this Profile
D
Development of the coreHEM mental health patient-reported outcome measure - A novel mental health outlook measure for people with haemophilia.
Elizabeth Clearfield, Hsing-Yuan Chang, Ellen M Janssen, Tabassum Majid, Donna A Messner

Haemophilia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life.
Purnadeo N Persaud, Annie P Tran, Donna Messner, J Daryl Thornton, Dennis Williams

Ann Allergy Asthma Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the Patient-Centeredness of Health Economics and Outcomes Research Through Patient Engagement in Core Outcome Set Development.
Elizabeth Clearfield, Ellen Tambor, Ellen M Janssen, Donna A Messner

Patient· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
coreNASH: Multi-stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis Treatment.
Elizabeth Clearfield, Veronica Miller, Joseph Nadglowski, Katherine Barradas, Jennifer Al Naber, Donna A Messner

Hepatol Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed framework for patient-centered outcomes-based measures in alternative payment models.
Rachael M Moloney, Donna A Messner, Zachary Wessler, Sean R Tunis

Am J Manag Care· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The increasing complexity of the core outcomes landscape.
Rachael M Moloney, Donna A Messner, Sean R Tunis

J Clin Epidemiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paying for Cures: Perspectives on Solutions to the "Affordability Issue".
Sarah Karlsberg Schaffer, Donna Messner, Jorge Mestre-Ferrandiz, Ellen Tambor, Adrian Towse

Value Health· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
Paula Darby Lipman, Kirsty Loudon, Leanora Dluzak, Rachael Moloney, Donna Messner

Trials· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-stakeholder Consensus.
Robert B Conley, Dane Dickson, Jean Claude Zenklusen, Jennifer Al Naber, Donna A Messner

Cell· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to clinical adoption of next-generation sequencing: a policy Delphi panel's solutions.
Donna A Messner, Pei Koay, Jennifer Al Naber, Robert Cook-Deegan, Mary Majumder

Per Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Payer Perspectives on Coverage of Biomarker Testing in Cardiovascular Disease.
Sean R Tunis, Donna A Messner

Clin Chem· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding practice-based research participation: The differing motivations of engaged vs. non-engaged clinicians in pragmatic clinical trials.
Donna A Messner, Rachael Moloney, Amy H Warriner, Nicole C Wright, Phillip J Foster

Contemp Clin Trials Commun· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel.
Donna A Messner, Jennifer Al Naber, Pei Koay, Robert Cook-Deegan, Mary Majumder

Appl Transl Genom· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncology.
Patricia Deverka, Donna A Messner, Robert McCormack, Gary H Lyman, Margaret Piper

Genet Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the comparative effectiveness of treatment sequences in oncology: a new approach.
Donna A Messner

J Comp Eff Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of comparative effectiveness and relative efficacy of drugs: an international perspective.
Donna A Messner, Adrian Towse, Penny Mohr, Martina Garau

J Comp Eff Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020.
Donna A Messner, Penny Mohr, Adrian Towse

J Comp Eff Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Futurescapes: expectations in Europe for relative effectiveness evidence for drugs in 2020.
Adrian Towse, Martina Garau, Penny Mohr, Donna A Messner

J Comp Eff Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medicare policy on bariatric surgery: decision making in the face of uncertainty.
Sean R Tunis, Donna A Messner

JAMA· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A translation table for patient-centered comparative effectiveness research: guidance to improve the value of research for clinical and health policy decision-making.
Sean R Tunis, Donna A Messner, Penny Mohr, Richard E Gliklich, Robert W Dubois

J Comp Eff Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating stakeholder perspectives in developing a translation table framework for comparative effectiveness research.
Richard E Gliklich, Michelle B Leavy, Priscilla Velentgas, Nancy A Dreyer, Sean R Tunis, Donna A Messner

J Comp Eff Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informed Choice in Direct-to-Consumer Genetic Testing for Alzheimer and Other Diseases: Lessons from Two Cases.
Donna A Messner

New Genet Soc· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on the impact of gene patents and licensing practices on access to genetic testing: lessons from hereditary hemorrhagic telangiectasia.
Donna A Messner, Reed E Pyeritz, Barbara A Bernhardt

Genet Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis